Wolverine Trading, LLC Catalyst Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $204,052 - $235,188	13,900 New	13,900 $215,000
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $265,825 - $423,150	21,700 Added 144.67%	36,700 $683,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $105,900 - $232,800	15,000 New	15,000 $191,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $41,760 - $60,600	-12,000 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$2.61 - $5.21 $522 - $1,042	200 Added 1.69%	12,000 $47,000
Q4 2019 Feb 12, 2020	SELL	$3.67 - $5.7 $11,377 - $17,670	-3,100 Reduced 20.81%	11,800 $43,000
Q2 2019 Aug 20, 2019	BUY	$2.7 - $6.11 $40,230 - $91,039	14,900 New	14,900 $57,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $44,160 - $83,260	-23,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $64,630 - $86,940	23,000 New	23,000 $87,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.